Key Insights

Highlights

Treatment Research

1 treatments under study, led by Liver Biopsy

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00834496Withdrawn

Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation

Showing all 1 trials

Research Network

Common Treatments

  • Liver Biopsy1

Active Sponsors

  • Thomas Jefferson University1
  • Wyeth is now a wholly owned subsidiary of Pfizer1

Top Investigators

Related Conditions

  • Neurotoxicity1
  • Renal Toxicity1
  • Side Effects Of Calcineurin Inhibitors1
  • Post Transplant Diabetes1

Activity Timeline